Page last updated: 2024-09-05

tolvaptan and foscarnet

tolvaptan has been researched along with foscarnet in 2 studies

Compound Research Comparison

Studies
(tolvaptan)
Trials
(tolvaptan)
Recent Studies (post-2010)
(tolvaptan)
Studies
(foscarnet)
Trials
(foscarnet)
Recent Studies (post-2010) (foscarnet)
9671727861,682116257

Protein Interaction Comparison

ProteinTaxonomytolvaptan (IC50)foscarnet (IC50)
DNA polymerase catalytic subunitHuman herpesvirus 5 strain AD1692.5
DNA polymerase catalytic subunitHuman herpesvirus 3 strain Dumas0.28
Reverse transcriptase/RNaseH Human immunodeficiency virus 12.42

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Gannamani, V; Nathan, S; Ustun, C; Varma, A1

Reviews

1 review(s) available for tolvaptan and foscarnet

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016

Other Studies

1 other study(ies) available for tolvaptan and foscarnet

ArticleYear
Human herpesvirus 6 (HHV-6) associated permanent hyponatremia in umbilical cord blood transplant recipient.
    Transplant immunology, 2023, Volume: 76

    Topics: Cord Blood Stem Cell Transplantation; Female; Foscarnet; Herpesvirus 6, Human; Humans; Hyponatremia; Inappropriate ADH Syndrome; Middle Aged; Roseolovirus Infections; Tolvaptan; Transplant Recipients; Viremia

2023